ASMT EXPRESSION PROMOTER
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
May 27, 2021
app pub date -
Apr 5, 2018
filing date -
Apr 5, 2018
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The objective of the present invention is to provide a novel ASMT expression promoter. Provided are an ASMT expression promoter comprising ectoine or a physiologically acceptable salt thereof as an active ingredient, and a melatonin synthesis promoter comprising ectoine or a physiologically acceptable salt thereof as an active ingredient, which promotes melatonin synthesis through the promotion of ASMT expression. Effects such as improvement of sleep disorder, improvement of cognitive function, improvement of mood disorder, enhancement of antioxidant activity, and enhancement of anti-inflammatory activity can be enhanced by promoting melatonin synthesis through the promotion of ASMT expression.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully